Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Net Element Inc. (NASDAQ: NETE), Mullen Technologies Announce Facility Build-Out, Pre-Sales of Fully Electric EV

Mullen Technologies begins built-out of pilot facility, accepting orders for MX-05 SUV. Facility slated for April 2021 completion; first MX-05 SUVs rolling off production line by Q2 2022. In August, Net Element, Mullen Technologies announced execution of definitive agreement to merge. The announcement by Mullen Technologies Inc. that it has begun to build out its […]

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”

Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete […]

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF) Partners with Hub International to Expand Hospitality Liability Coverage

The partnership will help InsuraGuest’s coverage potentially reach more than 9,300 hospitality customers in the United States and Canada by the middle of 2021 Hospitality Liability coverage allows covered properties to transfer certain liabilities, lowering claim ratio and risk profiles InsuraGuest’s product can also help properties generate revenue by keeping a percent of the nightly […]

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in […]

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment […]

Sugarmade (SGMD) 8K Filing Notes Status, Potential of Upcoming LA-Based Cannabis-Delivery Locations

SGMD has filed updated Form 8K Current Report with SEC Filing includes information about issues related to company’s status, including planned expansion of BudCars cannabis-delivery service Sugarmade sees “major business opportunities out of both sites once operations begin” Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, […]

Rritual Mushrooms Inc. is “One to Watch”

Rritual’s suite of premium functional mushroom and adaptogenic elixirs is designed to offer various health benefits, such as increased immunity, cognitive function, stress management and more The company’s products are expected to be available online through Rritual’s site and Amazon by fall 2020 The Rritual team has extensive ties and influential relationships with leading retail […]

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in Rapidly Growing Mushroom Space

Research shows psilocybin produces immediate, substantial and sustained improvements in anxiety and depression Global medicinal mushroom market projected to increase by almost $14 billion annually for the next several years Pure Extracts is a plant-based extraction company with new vertical in the mushroom space Recent groundbreaking research indicates that psilocybin-assisted psychotherapy may be effective in […]

VistaGen Therapeutics Inc. (NASDAQ: VTGN) is “One to Watch”

VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders Two of the company’s drug candidates have received an FDA fast track designation, including for the treatment of social anxiety disorder, major depressive disorder and neuropathic pain. The global CNS therapeutics market is estimated to […]

Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure

The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15 million patients indirectly through these networks of pharmacies Pharmaceutical supplies and services provider Trxade Group (NASDAQ: MEDS) benefited from an […]

 

From Our Blog

Xeriant Inc. (XERI) Builds Innovation Ecosystem Focused on Advanced Technologies, Commercialization

February 6, 2026

As investor interest in advanced technology platforms grows alongside breakthroughs in research, materials science and data-driven innovation, Xeriant (OTCQB: XERI) is shaping a strategy that extends well beyond any single product or material solution. Rather than positioning itself as a one-technology company, Xeriant is increasingly defining its identity around building an integrated innovation ecosystem focused […]

Rotate your device 90° to view site.